Summary
The addition of different amounts of hydroxyapatite crystals (HAP) to a solution, metastably supersaturated with respect to calcium oxalate (CaOx) resulted in heterogenous crystallization at seed concentrations exceeding 0.2 mmol/l. The induction period varied between 1 and more than 8 h with the shortest period for a seed concentration of 2 mmol/l. Addition to the system of 1 and 2% of whole urine and citrate in concentrations corresponding to approximately 1% of that found in normal urine inhibited the crystallization for as long as 4 h. In a system supersaturated with respect to calcium phosphate (CaP) the total number of crystals was markedly reduced by citrate concentrations exceeding 0.5 mmol/l. The fractions of medium sized and large crystals were sharply reduced and small crystals predominated at higher citrate concentrations. This might indicate effects of citrate on both crystal growth and crystal aggregation. We conclude that increased citrate concentrations during treatment with alkali leads to a significant inhibition of CaOx growth on HAP as well as to a prevention of the formation of large CaP crystals from solutions supersaturated with respect to CaP.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Berg C, Tiselius HG (1986) The effect of pH on the risk of calcium oxalate crystallization in urine. Eur Urol 12:59–61
Bisaz S, Felix R, Nejman WF, Fleisch H (1978) Quantitative determination of inhibitors of calcium phosphate crystal formation in whole urine. Miner Electrolyte Metab 1:74–83
Butz M, Dulce HJ (1981) Enhancement of urinary citrate in oxalate stone formers by the intake of alkaline salts. In: Smith LH, Robertson WG, Finlayson B (eds) Urolithiasis: clinical and basic research. Plenum Press, New York, pp 881–884
Butz M (1986) First long-term results of oxalate stone prevention by alkaline citrate. Urol Res 14:95
Hallson PC, Rose GA, Sulaiman S (1983) Raising urinary citrate lowers calcium oxalate and calcium phosphate crystal formation in whole urine. Urol Int 38:179–181
Hesse A, Böhmer I, Classen A, Vahlensieck W (1986) Prophylaxis of urinary stones with a mixture of potassium-sodium-citrate (in German). Münch Med Wochenschr 128:90–93
Kok DJ, Papapoulos SE, Bijvoet OLM (1986) Excessive crystal agglomeration with low citrate exeretion in recurrent stone formers. Lancet I:1056–1058
Koutsoukos PG, Sheehan ME, Nancollas GH (1981) Epitaxial considerations in urinary stone formation. II. The oxalatephosphate system. Invest Urol 18:358–363
Lonsdale KD (1968) Epitaxy as a growth factor in urinary calculi and gallstones. Nature 217:56–58
Lonsdale KD, Sutor DJ, Wooley WE (1968) Composition of urinary calculi by x-ray diffraction collected data from various localities. II. Czechoslovakia. Br J Urol 40:402–411
Meyer JL, Bergert JH, Smith LH (1975) Epitaxial relationship in urolithiasis: the calcium oxalate monohydrate-hydroxyapatite system. Clin Sci Mol Med 49:369–374
Meyer JL, Bergert JH, Smith LH (1975) Epitaxial relationships in urolithiasis: the brushite-whewellite system. Clin Sci Mol Med 52:143–148
Nancollas GH, Mohan MS (1970) The growth of hydroxyapatite crystals. Arch Oral Biol 15:731–745
Nancollas GH, Gardner GL (1974) Kinetics of crystal growth of calcium oxalate monohydrate. J Crystal Growth 21:267–276
Pak CYC (1981) Potential etiologic role of brushite in the formation of calcium (renal) stones. J Crystal Growth 53:202–208
Pak CYC Fuller C, Sakhaee K, Preminger GM, Britton F (1985) Long-term treatment of calcium nephrolithiasis with potessium citrate. J Urol 134:11–19
Scott WW, Huggins C, Selman BC (1943) Metabolism of citric acid in urolithiasis. J Urol 50:202–209
Sutor DJ (1971) Crystallographic studies on the formation of renal calculi. Biochem J 122:6–7
Tiselius HG (1981) Urinary excretion of citrate in normal subjects and patients with urolithiasis. In: Smith LH, Robertson WG, Finlayson B (eds) Urolithiasis: clinical and basic reasearch. Plenum Press, New York, pp 39–44
Tiselius HG, Formander AM (1981) Evaluation of a routine method for determination of calcium oxalate crystal growth inhibition in diluted urine samples. Clin Chem 27:565–568
Tiselius HG (1985) Urine composition in calcium oxalate stone formers during treatment with alkali. In: Schwille PO, Smith LH, Robertson WG, Vahlensieck W (eds) Urolithiasis and related clinical research. Plenum Press, New York, pp 533–536
Werness PG, Brown CM, Smith LH, Finlayson B (1985) EQUIL 2: a BASIC computer program for the calculation of urinary saturation. J Urol 134:1242–1244
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Berg, C., Tiselius, HG. The effects of citrate on hydroxyapatite induced calcium oxalate crystallization and on the formation of calcium phosphate crystals. Urol. Res. 17, 167–172 (1989). https://doi.org/10.1007/BF00256245
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00256245